Abstract
Pneumococcal bloodstream infections in pediatric patients rose from 3.6 to 14.8 episodes per 100,000 from 1986 to the year 2000 (P < 0.001) in a population of approximately 650,000 inhabitants (16% <16 years of age). Incidence in the group <24 months of age increased from 7.4 to 78.6 episodes per 100,000 per year (P < 0.001). Overall 75% of the serogroups are included in the new heptavalent vaccine.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Age Distribution
-
Anti-Bacterial Agents
-
Bacteremia / diagnosis
-
Bacteremia / epidemiology*
-
Chi-Square Distribution
-
Child
-
Child, Preschool
-
Drug Therapy, Combination / therapeutic use
-
Female
-
Humans
-
Incidence
-
Infant
-
Linear Models
-
Male
-
Microbial Sensitivity Tests
-
Pneumococcal Infections / drug therapy
-
Pneumococcal Infections / epidemiology*
-
Pneumococcal Infections / prevention & control
-
Pneumococcal Vaccines / administration & dosage
-
Probability
-
Registries
-
Retrospective Studies
-
Risk Factors
-
Severity of Illness Index
-
Sex Distribution
-
Spain / epidemiology
-
Streptococcus pneumoniae / isolation & purification
-
Survival Rate
-
Vaccination / standards
-
Vaccination / trends
Substances
-
Anti-Bacterial Agents
-
Pneumococcal Vaccines